Sodium Iodide → (S)-tert-butyl 5-((6-bromo-2-methoxynaphthalen-1-yl)methyl)-4-oxo-9-(trifluoromethyl)-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-ylcarbamate
反応式
[O:1]=[C:2]1[C@@H:8]([NH:9][C:10](=[O:16])[O:11][C:12]([CH3:15])([CH3:14])[CH3:13])[CH2:7][O:6][C:5]2[C:17]([C:21]([F:24])([F:23])[F:22])=[CH:18][CH:19]=[CH:20][C:4]=2[NH:3]1.[Br:25][C:26]1[CH:27]=[C:28]2[C:33](=[CH:34][CH:35]=1)[C:32]([CH2:36]Cl)=[C:31]([O:38][CH3:39])[CH:30]=[CH:29]2.[Na+].[I-].C([O-])([O-])=O.[Cs+].[Cs+]>CN(C=O)C.CCOC(C)=O>[Br:25][C:26]1[CH:27]=[C:28]2[C:33](=[CH:34][CH:35]=1)[C:32]([CH2:36][N:3]1[C:2](=[O:1])[C@@H:8]([NH:9][C:10](=[O:16])[O:11][C:12]([CH3:13])([CH3:14])[CH3:15])[CH2:7][O:6][C:5]3[C:17]([C:21]([F:24])([F:22])[F:23])=[CH:18][CH:19]=[CH:20][C:4]1=3)=[C:31]([O:38][CH3:39])[CH:30]=[CH:29]2参加物
7
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
A mixture of (S)-tert-butyl 4-oxo-9-(trifluoromethyl)-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-ylcarbamate (389 mg, 1.12 mmol), 6-bromo-1-(chloromethyl)-2-methoxynaphthalene (481 mg, 1.68 mmol), NaI (253 mg, 1.68 mmol) and Cs2CO3 (549 mg, 1.68 mmol) in DMF (15.6 mL) was stirred at RT for 6 h and diluted with EtOAc. The mixture was washed with brine, dried over Na2SO4, filtered and the filtrate concentrated to give a residue that was purified by silica gel chromatography to afford (S)-tert-butyl 5-((6-bromo-2-methoxynaphthalen-1-yl)methyl)-4-oxo-9-(trifluoromethyl)-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-ylcarbamate (321 mg, 48%) as a colorless waxy solid. MS m/z 617/619 (MNa)+
後処理
- washThe mixture was washed with brine
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationthe filtrate concentrated
- customto give a residue that
- customwas purified by silica gel chromatography
出典と根拠
- ORDレコード
- ord-eff18eaebfb84a8f815a23ec49571830
- 出典データセット
- uspto-grants-2016_07
- 特許番号
- US09394263B2
反応ノート
読み込み中…